🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

25 results for “Akebia Europe Limited” Clear

  1. Epoetin alga (Epogen)/vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  2. Erythropoiesis-Stimulating Agent (ESA)

    Akebia Europe Limited

    Anemia of Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  3. Ferric Citrate 1 GM Oral Tablet [AURYXIA]

    Akebia Europe Limited

    Anemia, Iron Deficiency

    phase 3 small molecule completed

    1 trial

  4. Vadadustat

    Akebia Europe Limited

    Anemia

    phase 3 small molecule completed

    10 trials

  5. Vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease (CKD)

    phase 3 small molecule completed

    1 trial

  6. Vadadustat

    Akebia Europe Limited

    Anemia of Chronic Kidney Disease

    phase 3 small molecule active

    3 trials

  7. Vadadustat 900mg

    Akebia Europe Limited

    Nonintubated Acute Respiratory Distress Syndrome (ARDS)

    phase 3 small molecule active

    1 trial

  8. AKB-6548

    Akebia Europe Limited

    Anemia

    phase 2 small molecule completed

    4 trials

  9. IW-1973

    Akebia Europe Limited

    Type 2 Diabetes Mellitus With Diabetic Nephropathy

    phase 2 small molecule completed

    1 trial

  10. IW-1973

    Akebia Europe Limited

    Heart Failure With Preserved Ejection Fraction

    phase 2 small molecule completed

    1 trial

  11. Praliciguat

    Akebia Europe Limited

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule active

    1 trial

  12. Vadadustat

    Akebia Europe Limited

    Chronic Kidney Disease

    phase 2 small molecule completed

    1 trial

  13. vadadustat

    Akebia Europe Limited

    Acute Respiratory Distress Syndrome

    phase 2 small molecule completed

    1 trial

  14. AKB-6548

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. AKB-6548 (therapeutic dose)

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. AKB-6548 tablet, reference formulation given in the fasted state

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  17. AKB-9090

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  18. Celecoxib

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. Vadadustat

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease

    phase 1 small molecule completed

    1 trial

  21. Vadadustat

    Akebia Europe Limited

    Drug Interaction Potentiation

    phase 1 small molecule completed

    4 trials

  22. Vadadustat

    Akebia Europe Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  23. vadadustat

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  24. vadadustat reference tablets

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources